Oklo Inc. (NYSE: OKLO) announced that its wholly owned subsidiary, Atomic Alchemy, has received approval from the U.S. Department of Energy (DOE) for its Nuclear Safety Design Agreement (NSDA). This approval pertains to the Groves Isotopes Test Reactor located in Texas, marking a significant regulatory milestone for the company. The agreement is a key component of the DOE's Reactor Pilot Program (RPP), aimed at advancing innovative nuclear technologies. This development follows an Other Transaction Agreement (OTA) previously signed in January, demonstrating continued progress in the project's regulatory framework. By securing this approval, Oklo moves closer to the implementation phase of its advanced nuclear testing infrastructure. Analysts view this as a positive de-risking event for OKLO shares, as it validates the company's path through complex federal safety requirements.
Sign up free to access this content
Create Free Account